The Latest Data Specifically Focused on Long-Term Oncologic Prognostication for Very Old Adults with Acute Vulnerable Localized Prostate Cancer: A Nationwide Cohort Study
- PMID: 35743522
- PMCID: PMC9225393
- DOI: 10.3390/jcm11123451
The Latest Data Specifically Focused on Long-Term Oncologic Prognostication for Very Old Adults with Acute Vulnerable Localized Prostate Cancer: A Nationwide Cohort Study
Abstract
Purpose: Few studies have evaluated the prime treatment choice for men older than 80 years with acute vulnerable localized prostate cancer (AV-LPC). Clinicians have been deeply troubled by this near end-of-life medical choice for a very specific group of patients. We compared the oncological prognostication of very old patients with AV-LPC after they underwent either radical prostatectomy (RP) or massive-dose intensity-modulated radiotherapy (IMRT) coupled with long-term androgen deprivation therapy (ADT) over a long-term investigation. Methods: In this nationwide cohort study, we used the Taiwan Cancer Registry Database and retrieved information related to patients (aged ≥ 80 years) with AV-LPC who underwent standard RP (the RP group) or massive-dose IMRT + long-term ADT (at least 72 Gy and ADT use ≥18 months; the IMRT + ADT group). After potential confounders were controlled for using propensity score matching (PSM), we utilized the Cox proportional hazards regression to evaluate the oncologic prognostication. Results: The IMRT + ADT group had a significantly higher adjusted hazard ratio (aHR) for all-cause mortality (aHR, 2.00; 95% confidence interval [CI], 1.41−2.87) than the RP group. Analysis of the secondary outcomes revealed that compared with the RP group, the aHRs of biochemical failure, locoregional recurrence, and distant metastasis in the IMRT + ADT group were 1.77 (95% CI: 1.36−2.11, p < 0.0001), 1.12 (95% CI: 1.04−1.33, p < 0.0001), and 1.15 (95% CI: 1.06−1.71, p = 0.0311), respectively. Conclusion: RP provides more favorable oncological prognostication than IMRT in very old adults with AV-LPC.
Keywords: acute vulnerable; intensity-modulated radiotherapy; oncologic prognostication; prostate cancer; radical prostatectomy.
Conflict of interest statement
The authors have no potential conflict of interest to declare. The data sets supporting the study conclusions are included in the manuscript.
Figures
Similar articles
-
Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer.Cancers (Basel). 2021 Nov 28;13(23):5986. doi: 10.3390/cancers13235986. Cancers (Basel). 2021. PMID: 34885096 Free PMC article.
-
Oncologic Outcomes of Radical Prostatectomy and High-Dose Intensity-Modulated Radiotherapy with Androgen-Deprivation Therapy for Relatively Young Patients with Unfavorable Intermediate-Risk Prostate Adenocarcinoma.Cancers (Basel). 2021 Mar 25;13(7):1517. doi: 10.3390/cancers13071517. Cancers (Basel). 2021. PMID: 33806181 Free PMC article.
-
Long-Term Medical Resource Consumption of Radical Prostatectomy vs. Intensity-Modulated Radiotherapy for Old Patients With Prostate Cancer: A Nationwide Population-Based Cohort Study.Front Med (Lausanne). 2022 May 3;9:843709. doi: 10.3389/fmed.2022.843709. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35592854 Free PMC article.
-
Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus. 2020 Mar 15;6(2):404-418. doi: 10.1016/j.euf.2019.11.007. Epub 2019 Dec 5. Eur Urol Focus. 2020. PMID: 31813810
-
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.Eur Urol. 2020 May;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033. Epub 2020 Mar 4. Eur Urol. 2020. PMID: 32146018
Cited by
-
Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis.Strahlenther Onkol. 2024 Aug;200(8):676-683. doi: 10.1007/s00066-023-02192-5. Epub 2024 Jan 5. Strahlenther Onkol. 2024. PMID: 38180494 Free PMC article.
-
Efficacy and Complications of the Re-Adjustable Male Sling System for Stress Urinary Incontinence after Radical Prostatectomy.J Clin Med. 2022 Nov 15;11(22):6764. doi: 10.3390/jcm11226764. J Clin Med. 2022. PMID: 36431241 Free PMC article.
References
-
- World Cancer Research Fund International Prostate Cancer Statistics. [(accessed on 5 October 2021)]. Available online: https://www.wcrf.org/dietandcancer/prostate-cancer-statistics/
LinkOut - more resources
Full Text Sources
Miscellaneous